Risk Evaluation And Mitigation Strategy
A risk evaluation and mitigation strategy rems is a drug safety program that the u s.
Risk evaluation and mitigation strategy. A risk evaluation and mitigation strategy rems is a program to manage known or potential serious risks associated with a drug product and is required by the food and drug administration fda to ensure that the benefits of the drug outweigh its risks. The food and drug administration amendments act of 2007 fdaaa created section 505 1 of the food drug and cosmetic fd c act 21 usc 355 1 which authorizes fda to require a rems for certain drugs. A risk evaluation and mitigation strategy rems is a formal plan required by the fda for certain riskier drugs to ensure that the benefits of these drugs outweigh their risks. The fda has required a rems for kymriah tisagenlecleucel.
The food and drug administration amendments act of 2007 gave fda the authority to require a risk evaluation and mitigation strategy rems from manufacturers to ensure that the benefits of a drug.